SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-018699
Filing Date
2021-04-13
Accepted
2021-04-13 16:15:20
Documents
5
Period of Report
2021-05-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A onct-def14a_20210525.htm DEF 14A 981224
2 GRAPHIC gdrwuklmdfua000004.jpg GRAPHIC 52453
3 GRAPHIC gdrwuklmdfua000001.jpg GRAPHIC 4172
4 GRAPHIC gdrwuklmdfua000003.jpg GRAPHIC 80583
5 GRAPHIC gdrwuklmdfua000002.jpg GRAPHIC 4172
  Complete submission text file 0001564590-21-018699.txt   1177598
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50549 | Film No.: 21823241
SIC: 2834 Pharmaceutical Preparations